Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 30, 2024 03:01 ET
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiatives
Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, announced that Persistent Systems, a global organization delivering digital engineering enterprise modernization services and solutions, is leveraging the Zscaler Zero Trust ExchangeTM cloud...
May 30, 2024 03:00 ET
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer Indicated in Patients With Prostate Cancer
Curium, a world leader in nuclear medicine, today announced that earlier this month patients in France received the first doses of PYLCLARI® (INN: Piflufolastat (18F) also known as (18F)-DCFPyL) indicated for the detection of prostate-specific...
May 30, 2024 03:00 ET
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutraceutical Product, GBL-Memory¹
A clinical study, published in the journal Food Science and Nutrition, showed that GBL-Memory1, a unique combination of L-theanine and Fructooligosaccharides, can improve memory by up to 10.1% GBL-Memory1 is the first nutraceutical product launched...
May 30, 2024 02:35 ET
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
Tokyo, Japan and Cambridge, UK, 30 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) today announced that it expects to receive $4.6 million in milestone payments from Centessa Pharmaceuticals pursuant to a license agreement regarding...
May 30, 2024 02:30 ET
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease cell therapy candidate bemdaneprocel
Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly owned independently operated subsidiary of Bayer AG, announced today that BlueRock’s investigational cell therapy bemdaneprocel for the treatment of Parkinson’s...
May 30, 2024 02:30 ET
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
Daix (France), Long Island City (New York, United States), May 30, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of...
May 30, 2024 02:30 ET
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
Expansion of existing partnership will utilize novel insights into causal biology within auto-immune disorders to identify novel targets for drug discovery Tokyo, Japan, Oxford and Cambridge, UK, 30 May 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE...
May 30, 2024 02:01 ET
Renewi announces sale of UK Municipal business to Biffa
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 (“MAR”) AND MAR WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED (“UK MAR”) 30 May 2024 Renewi plc...
May 30, 2024 02:00 ET
Endeavour Announces Wet Commissioning is Underway at Lafigué Project
ENDEAVOUR ANNOUNCES WET COMMISSIONING IS UNDERWAY AT LAFIGUÉ PROJECT First gold expected in late-June · Project ahead of schedule and on budget · 94% project completion   HIGHLIGHTS: Wet commissioning of the...
May 30, 2024 02:00 ET
FY24 Full Year Results, Delivering on Commitments
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 (“MAR”), AND MAR WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED (“UK MAR”) 30 May 2024 Renewi plc...
May 30, 2024 02:00 ET
Galantas Report Financial Results for the Quarter Ended March 31, 2024
Galantas Gold Corporation (the ‘Company’) is pleased to announce its unaudited financial results for the Quarter ended March 31, 2024. Financial Highlights Highlights of the first quarter 2024 results, which are expressed in Canadian Dollars, are...
May 30, 2024 02:00 ET
Unaudited interim results for the three-month period ended 31 March 2024
Unaudited interim results for the three-month period ended 31 March 2024 Serabi (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian focused gold mining and development company, is pleased to release its unaudited results for the three-month period...
May 30, 2024 01:30 ET
Moody’s selects TomTom location data for its risk management solutions
TomTom (TOM2), the location technology specialist, today announced its location data has been selected by Moody’s, a global, integrated risk assessment firm that empowers organizations to make better decisions, using its data, analytical solutions...
May 30, 2024 01:28 ET
FRO – First Quarter 2024 Results
FRONTLINE PLC REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2024 Frontline plc (the “Company” or “Frontline”), today reported unaudited results for the three months ended March 31, 2024: Highlights Profit of $180.8 million, or $0.81 per...
May 30, 2024 01:14 ET
SmartConnect Earns Prestigious Title of Xiaomi Internet Business' 2023 Agency of the Year
Earlier this year, the Xiaomi Internet Partner Conference (MIPC) unfolded. At this zenith event, SmartConnect was unveiled as the esteemed Agency of the Year for 2023 by Xiaomi's Internet Business Department. This recognition underscores...
May 30, 2024 00:00 ET
World No Tobacco Day: Addressing the "Misperception Epidemic"
On this World No Tobacco Day, the World Vapers Alliance (WVA) is shedding light on the rampant misperception epidemic around tobacco harm reduction. As revealed by Ipsos research for the think tank, We are Innovation, a staggering 74% of smokers...
May 29, 2024 23:11 ET
Regenx Announces Filing of Annual Documents
Regenx Tech Corp., (the “Company” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN:A2DSW3) announces that, further to its news releases dated April 12th, May 1st, May 13th and May 24th 2024, the Corporation has filed its annual financial...
May 29, 2024 23:00 ET
Microchip Technology Announces Pricing of Offering of $1.1 Billion of Convertible Senior Notes
(NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced the pricing of $1.1 billion aggregate principal amount of Convertible Senior Notes due 2030 (the...
May 29, 2024 22:48 ET
UNITEDHEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against UnitedHealth Group Inc.- UNH
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 15, 2024 to file lead plaintiff applications in a securities class action lawsuit against UnitedHealth Group Inc. (NYSE: UNH), if they purchased the...
May 29, 2024 22:47 ET
INARI MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 12, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inari Medical, Inc. (NasdaqGS: NARI), if they purchased the...